PRDM1/Blimp1 downregulates expression of germinal center genes LMO2 and HGAL

FEBS Journal

Volumn 278, Issue 17, 2011, Pages 3065-3075

  Cubedo, Elena ^a   Maurin, Michelle ^b   Jiang, Xiaoyu ^a   Lossos, Izidore S ^a   Wright, Kenneth L ^b  

^a UNIVERSITY OF MIAMI   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Blimp 1; HGAL; LMO2; non Hodgkin's B cell lymphoma; transcription

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; MESSENGER RNA;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LOSS; GENE REPRESSION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN GERMINAL CENTER ASSOCIATED LYMPHOMA GENE; IN VIVO STUDY; LIM DOMAIN ONLY 2 GENE; LYMPHATIC SYSTEM TUMOR; LYMPHOCYTE DIFFERENTIATION; ONCOGENE; PLASMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

B-LYMPHOCYTES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; DOWN-REGULATION; GENES, REPORTER; HUMANS; LYMPHOMA, B-CELL; METALLOPROTEINS; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84860389649     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08227.x     Document Type: Article

References (56)

1. MacLennan IC, (1994) Germinal centers. Annu Rev Immunol 12, 117-139. (Pubitemid 24140411)
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511. (Pubitemid 30082188)
3. Klein U, Tu Y, Stolovitzky GA, Keller JL, Haddad J Jr, Miljkovic V, Cattoretti G, Califano A, &, Dalla-Favera R, (2003) Transcriptional analysis of the B cell germinal center reaction. Proc Natl Acad Sci USA 100, 2639-2644. (Pubitemid 36297551)
4. Natkunam Y, Lossos IS, Taidi B, Zhao S, Lu X, Ding F, Hammer AS, Marafioti T, Byrne GE Jr, Levy S, et al. (2005) Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation. Blood 105, 3979-3986. (Pubitemid 40656146)
5. Natkunam Y, Zhao S, Mason DY, Chen J, Taidi B, Jones M, Hammer AS, Hamilton Dutoit S, Lossos IS, &, Levy R, (2007) The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 109, 1636-1642. (Pubitemid 46239598)
6. Lossos IS, Alizadeh AA, Rajapaksa R, Tibshirani R, &, Levy R, (2003) HGAL is a novel interleukin-4-inducible gene that strongly predicts survival in diffuse large B-cell lymphoma. Blood 101, 433-440. (Pubitemid 36077560)
7. Azambuja D, Lossos IS, Biasoli I, Morais JC, Britto L, Scheliga A, Pulcheri W, Natkunam Y, &, Spector N, (2009) Human germinal center-associated lymphoma protein expression is associated with improved failure-free survival in Brazilian patients with classical Hodgkin lymphoma. Leuk Lymphoma 50, 1830-1836.
8. Durnick DK, Law ME, Maurer MJ, Natkunam Y, Levy R, Lossos IS, Kurtin PJ, &, McPhail ED, (2010) Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphoma. Am J Clin Pathol 134, 278-281.
9. Lossos IS, Czerwinski DK, Alizadeh AA, Wechser MA, Tibshirani R, Botstein D, &, Levy R, (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 350, 1828-1837. (Pubitemid 38917249)
10. Natkunam Y, Farinha P, Hsi ED, Hans CP, Tibshirani R, Sehn LH, Connors JM, Gratzinger D, Rosado M, Zhao S, et al. (2008) LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. J Clin Oncol 26, 447-454. (Pubitemid 351171698)
11. Christoph T, Rickert R, &, Rajewsky K, (1994) M17: a novel gene expressed in germinal centers. Int Immunol 6, 1203-1211. (Pubitemid 24254124)
12. Lu X, Chen J, Malumbres R, Cubedo Gil E, Helfman DM, &, Lossos IS, (2007) HGAL, a lymphoma prognostic biomarker, interacts with the cytoskeleton and mediates the effects of IL-6 on cell migration. Blood 110, 4268-4277. (Pubitemid 351377791)
13. Lu X, Kazmierczak K, Jiang X, Jones M, Watt J, Helfman DM, Moore JR, Szczesna-Cordary D, &, Lossos IS, (2011) Germinal center-specific protein human germinal center associated lymphoma directly interacts with both myosin and actin and increases the binding of myosin to actin. FEBS J 278, 1922-1931.
14. Jiang X, Lu X, McNamara G, Liu X, Cubedo E, Sarosiek KA, Sanchez-Garcia I, Helfman DM, &, Lossos IS, (2010) HGAL, a germinal center specific protein, decreases lymphoma cell motility by modulation of the RhoA signaling pathway. Blood 116, 5217-5227.
15. McCormack MP, Forster A, Drynan L, Pannell R, &, Rabbitts TH, (2003) The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development. Mol Cell Biol 23, 9003-9013. (Pubitemid 37499791)
16. McCormack MP, Young LF, Vasudevan S, de Graaf CA, Codrington R, Rabbitts TH, Jane SM, &, Curtis DJ, (2010) The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science 327, 879-883.
17. Yamada Y, Pannell R, Forster A, &, Rabbitts TH, (2000) The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci USA 97, 320-324. (Pubitemid 30055829)
18. Landry JR, Bonadies N, Kinston S, Knezevic K, Wilson NK, Oram SH, Janes M, Piltz S, Hammett M, Carter J, et al. (2009) Expression of the leukemia oncogene Lmo2 is controlled by an array of tissue-specific elements dispersed over 100 kb and bound by Tal1/Lmo2, Ets, and Gata factors. Blood 113, 5783-5792.
19. Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, &, Rabbitts TH, (1994) The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 78, 45-57. (Pubitemid 24228299)
20. Turner CA Jr, Mack DH, &, Davis MM, (1994) Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77, 297-306. (Pubitemid 24138626)
21. Gong D, &, Malek TR, (2007) Cytokine-dependent Blimp-1 expression in activated T cells inhibits IL-2 production. J Immunol 178, 242-252. (Pubitemid 46033607)
22. Kallies A, Hawkins ED, Belz GT, Metcalf D, Hommel M, Corcoran LM, Hodgkin PD, &, Nutt SL, (2006) Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance. Nat Immunol 7, 466-474.
23. Martins GA, Cimmino L, Shapiro-Shelef M, Szabolcs M, Herron A, Magnusdottir E, &, Calame K, (2006) Transcriptional repressor Blimp-1 regulates T cell homeostasis and function. Nat Immunol 7, 457-465.
24. Rutishauser RL, Martins GA, Kalachikov S, Chandele A, Parish IA, Meffre E, Jacob J, Calame K, &, Kaech SM, (2009) Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31, 296-308.
25. Kallies A, Carotta S, Huntington ND, Bernard NJ, Tarlinton DM, Smyth MJ, &, Nutt SL, (2011) A role for Blimp1 in the transcriptional network controlling natural killer cell maturation. Blood 117, 1869-1879.
26. Smith MA, Maurin M, Cho HI, Becknell B, Freud AG, Yu J, Wei S, Djeu J, Celis E, Caligiuri MA, et al. (2010) PRDM1/Blimp-1 controls effector cytokine production in human NK cells. J Immunol 185, 6058-6067.
27. Chan YH, Chiang MF, Tsai YC, Su ST, Chen MH, Hou MS, &, Lin KI, (2009) Absence of the transcriptional repressor Blimp-1 in hematopoietic lineages reveals its role in dendritic cell homeostatic development and function. J Immunol 183, 7039-7046.
28. Smith MA, Wright G, Wu J, Tailor P, Ozato K, Chen X, Wei S, Piskurich JF, Ting JP, &, Wright KL, (2011) Positive regulatory domain 1 (PRDM1) and IRF8/Pu.1 counter regulate MHC class II transactivator (CIITA) expression during dendritic cell maturation. J Biol Chem 286, 7893-7904.
29. Gyory I, Wu J, Fejer G, Seto E, &, Wright KL, (2004) PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing. Nat Immunol 5, 299-308. (Pubitemid 38332127)
30. Yu J, Angelin-Duclos C, Greenwood J, Liao J, &, Calame K, (2000) Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. Mol Cell Biol 20, 2592-2603. (Pubitemid 30152065)
31. Ancelin K, Lange UC, Hajkova P, Schneider R, Bannister AJ, Kouzarides T, &, Surani MA, (2006) Blimp1 associates with Prmt5 and directs histone arginine methylation in mouse germ cells. Nat Cell Biol 8, 623-630. (Pubitemid 43827356)
32. Su ST, Ying HY, Chiu YK, Lin FR, Chen MY, &, Lin KI, (2009) Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation. Mol Cell Biol 29, 1421-1431.
33. Kuo TC, &, Calame KL, (2004) B lymphocyte-induced maturation protein (Blimp)-1, IFN regulatory factor (IRF)-1, and IRF-2 can bind to the same regulatory sites. J Immunol 173, 5556-5563. (Pubitemid 39392142)
34. Shapiro-Shelef M, Lin KI, McHeyzer-Williams LJ, Liao J, McHeyzer-Williams MG, &, Calame K, (2003) Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity 19, 607-620. (Pubitemid 37311441)
35. Shapiro-Shelef M, Lin KI, Savitsky D, Liao J, &, Calame K, (2005) Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J Exp Med 202, 1471-1476. (Pubitemid 41746593)
36. Savitsky D, &, Calame K, (2006) B-1 B lymphocytes require Blimp-1 for immunoglobulin secretion. J Exp Med 203, 2305-2314. (Pubitemid 44498365)
37. Messika EJ, Lu PS, Sung Y-J, Yao T, Chi J-T, Chien Y-H, &, Davis MM, (1998) Differential effect of B lymphocyte-induced maturation protein (Blimp-1) expression on cell fate during B cell development. J Exp Med 188, 515-525. (Pubitemid 28369141)
38. Pasqualucci L, Compagno M, Houldsworth J, Monti S, Grunn A, Nandula SV, Aster JC, Murty VV, Shipp MA, &, Dalla-Favera R, (2006) Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 203, 311-317. (Pubitemid 43290840)
39. Tam W, Gomez M, Chadburn A, Lee JW, Chan WC, &, Knowles DM, (2006) Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 107, 4090-4100. (Pubitemid 43726818)
40. Garcia JF, Roncador G, Sanz AI, Maestre L, Lucas E, Montes-Moreno S, Fernandez Victoria R, Martinez-Torrecuadrara JL, Marafioti T, Mason DY, et al. (2006) PRDM1/BLIMP-1 expression in multiple B- and T-cell lymphoma. Haematologica 91, 467-474.
41. Mandelbaum J, Bhagat G, Tang H, Mo T, Brahmachary M, Shen Q, Chadburn A, Rajewsky K, Tarakhovsky A, Pasqualucci L, et al. (2010) BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma. Cancer Cell 18, 568-579.
42. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, et al. (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17, 51-62. (Pubitemid 34874618)
43. Ghosh N, Gyory I, Wright G, Wood J, &, Wright KL, (2001) Positive regulatory domain I binding factor 1 silences class II transactivator expression in multiple myeloma cells. J Biol Chem 276, 15264-15268.
44. Lin KI, Angelin-Duclos C, Kuo TC, &, Calame K, (2002) Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol Cell Biol 22, 4771-4780. (Pubitemid 34620412)
45. Lin Y, Wong K, &, Calame K, (1997) Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science 276, 596-599. (Pubitemid 27193684)
46. Piskurich JF, Lin KI, Lin Y, Wang Y, Ting JP, &, Calame K, (2000) BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nat Immunol 1, 526-532.
47. Desai S, Maurin M, Smith MA, Bolick SC, Dessureault S, Tao J, Sotomayor E, &, Wright KL, (2010) PRDM1 is required for mantle cell lymphoma response to bortezomib. Mol Cancer Res 8, 907-918.
48. Ghosh N, Piskurich JF, Wright G, Hassani K, Ting JP, &, Wright KL, (1999) A novel element and a TEF-2-like element activate the major histocompatibility complex class II transactivator in B-lymphocytes. J Biol Chem 274, 32342-32350.
49. Wang X, Belguise K, O'Neill CF, Sanchez-Morgan N, Romagnoli M, Eddy SF, Mineva ND, Yu Z, Min C, Trinkaus-Randall V, et al. (2009) RelB NF-kappaB represses estrogen receptor alpha expression via induction of the zinc finger protein Blimp1. Mol Cell Biol 29, 3832-3844.
50. Steinke JW, Hodsdon W, Parenti S, Ostraat R, Lutz R, Borish L, &, Hagman J, (2004) Identification of an Sp factor-dependent promoter in GCET, a gene expressed at high levels in germinal center B cells. Mol Immunol 41, 1145-1153. (Pubitemid 39346263)
51. Wadman IA, Osada H, Grutz GG, Agulnick AD, Westphal H, Forster A, &, Rabbitts TH, (1997) The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J 16, 3145-3157. (Pubitemid 27234954)
52. Crable SC, &, Anderson KP, (2003) A PAR domain transcription factor is involved in the expression from a hematopoietic-specific promoter for the human LMO2 gene. Blood 101, 4757-4764. (Pubitemid 36857732)
53. Hammond SM, Crable SC, &, Anderson KP, (2005) Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. Leuk Res 29, 89-97. (Pubitemid 39487914)
54. Oram SH, Thoms JA, Pridans C, Janes ME, Kinston SJ, Anand S, Landry JR, Lock RB, Jayaraman PS, Huntly BJ, et al. (2010) A previously unrecognized promoter of LMO2 forms part of a transcriptional regulatory circuit mediating LMO2 expression in a subset of T-acute lymphoblastic leukaemia patients. Oncogene 29, 5796-5808.
55. Doody GM, Care MA, Burgoyne NJ, Bradford JR, Bota M, Bonifer C, Westhead DR, &, Tooze RM, (2010) An extended set of PRDM1/BLIMP1 target genes links binding motif type to dynamic repression. Nucleic Acids Res 38, 5336-5350.
56. Desai S, Bolick SC, Maurin M, &, Wright KL, (2009) PU.1 regulates positive regulatory domain I-binding factor 1/Blimp-1 transcription in lymphoma cells. J Immunol 183, 5778-5787.